Safety Study of the Effects of Inhaled Fluticasone Furoate/GW642444 on the Hypothalamic-Pituitary-Adrenal (HPA) Axis
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effect of six weeks' treatment with two once-daily
strengths of Fluticasone Furoate/GW642444 Inhalation Powder on the HPA axis system